Driehaus Capital Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-220,384	Closed	-$18.4M	–	400
2023 Q4	$18.4M	Buy	+220,384	New	+$7.98M	0.22%	144
2023 Q2	–	Sell	-365,348	Closed	-$12.9M	–	407
2023 Q1	$12.9M	Sell	365,348 -1,009	-0.3%	-$41.2K	0.18%	184
2022 Q4	$16.8M	Sell	366,357 -1,239,957	-77%	-$53.4M	0.25%	136
2022 Q3	$77.8M	Sell	1,606,314 -41,340	-3%	-$1.99M	1.18%	11
2022 Q2	$64.7M	Sell	1,647,654 -239,509	-13%	-$9.64M	1.05%	12
2022 Q1	$69.5M	Sell	1,887,163 -439,949	-19%	-$15.6M	0.85%	17
2021 Q4	$106M	Sell	2,327,112 -562,414	-19%	-$21.7M	1.08%	15
2021 Q3	$103M	Sell	2,889,526 -210,131	-7%	-$6.19M	1.22%	6
2021 Q2	$61.3M	Sell	3,099,657 -135,981	-4%	-$3.19M	0.81%	21
2021 Q1	$75.3M	Buy	3,235,638 +9,071	+0.3%	+$194K	1.11%	12
2020 Q4	$67M	Buy	3,226,567 +194,869	+6%	+$3.56M	1.08%	12
2020 Q3	$65.6M	Sell	3,031,698 -77,674	-2%	-$1.82M	1.35%	9
2020 Q2	$73.3M	Buy	3,109,372 +135,770	+5%	+$2.55M	1.78%	3
2020 Q1	$35.1M	Sell	2,973,602 -65,654	-2%	-$838K	1.17%	13
2019 Q4	$32.2M	Buy	3,039,256 +319,091	+12%	+$3.28M	0.86%	19
2019 Q3	$31M	Buy	2,720,165 +532,551	+24%	+$6.68M	1.01%	14
2019 Q2	$24.6M	Buy	+2,187,614	New	+$21.1M	0.77%	29
2014 Q3	–	Sell	-205,019	Closed	-$980K	–	547
2014 Q2	$980K	Sell	205,019 -19,379	-9%	-$118K	0.03%	448
2014 Q1	$2.13M	Buy	+224,398	New	+$2.03M	0.07%	323